Latest

psychopharmacology

·July 6, 2026·12 min read

Biomarkers Boost Antidepressant Success Rates by 67%

A new study demonstrates that combining fMRI brain connectivity, cognitive reward testing, and clinical markers to guide antidepressant selection increases patient response rates by nearly 67%.

Featured Neuroscience Psychology

·July 5, 2026·9 min read

Psychedelic Trips Can Halt Political Hate

The collective cultural mood surrounding a psychedelic experience shapes its psychological aftermath. Participants whose most intense trips occurred on the Fourth of July reported a long-term decrease in support for partisan violence, while those whose experiences coincided with national party conventions or election season demonstrated an increase in violent partisan support.

Featured Neuroscience Psychology

·June 30, 2026·11 min read

Creatine Shows Mixed Results in Treating Depression

A new study reveals a split decision on using creatine to treat depression. While combining creatine with standard therapy or antidepressants significantly accelerated remission in adult women, it failed in adolescent, treatment-resistant, and bipolar cohorts, even triggering mania in some bipolar patients.

Featured Neuroscience

·June 16, 2026·9 min read

Pairing Psilocybin With Stillness Could Permanently Rewire the Brain

Researchers aim to discover if mindfulness practices can provide the cognitive scaffolding necessary to sustain the intense neuroplastic states and narrative deconstruction induced by psilocybin therapy.

This shows a brain made of gut bacteria.

Featured Neuroscience Psychology

·June 10, 2026·9 min read

GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria

The GLP-1 agonist liraglutide treats depressive symptoms via a novel microbial pathway.

Featured Neuroscience Psychology

·June 8, 2026·8 min read

SSRIs Push Serotonin Neurons in Opposite Directions

A new study maps the distinct gene-expression changes induced by fluoxetine inside the brain's primary serotonin hub, the Dorsal Raphe Nucleus.

Featured Neuroscience Psychology

·June 3, 2026·8 min read

Are Long-Term Antidepressant Benefits Overstated?

A new study reveals a lack of robust evidence proving that antidepressants prevent relapse beyond 12 months.

This shows a depressed person and a pill bottle.

Featured Neuroscience Psychology

·May 20, 2026·12 min read

Arthritis Drug Rescues Hard-to-Treat Depression

The anti-inflammatory drug tocilizumab can successfully induce remission in patients struggling with treatment-resistant depression.

Featured Neuroscience Psychology

·May 19, 2026·16 min read

Buprenorphin and Ketamine Combo Provide Anti-Suicidal Effect

A sequential combination of a single ketamine infusion followed by four weeks of low-dose daily buprenorphine successfully extends the antisuicidal window of ketamine from one fleeting week to over a month.

Featured Neuroscience Psychology

·May 15, 2026·10 min read

Single Psilocybin Dose Sparks Rapid Depression Remission

Can a single dose of psilocybin replace daily antidepressants? A new randomized clinical trial shows that a 25 mg dose of the psychedelic compound delivers rapid, clinically meaningful symptom reductions for common depression in just 48 hours.

This shows a woman with a digital contact lense on her eye.

Featured Neuroscience Psychology Visual Neuroscience

·May 14, 2026·6 min read

Brain-Stimulating Contact Lenses Match Prozac in Depression Study

Researchers have created transparent, flexible contact lenses that treat depression using "temporal interference" electrical stimulation. In a landmark study, the lenses restored brain connectivity and boosted serotonin by 47%, matching the performance of leading antidepressants.

Featured Neuroscience Psychology

·May 7, 2026·9 min read

Psilocybin Rebuilds the Brain’s Physical Wiring

New research from UCSF shows that a single high dose of the psychedelic compound creates lasting anatomical changes in brain tracts and "loosens" rigid thought patterns, leading to significant improvements in psychological insight and well-being that persist for over a month.

1 2 3 … 42

psychopharmacology

Biomarkers Boost Antidepressant Success Rates by 67%

Psychedelic Trips Can Halt Political Hate

Creatine Shows Mixed Results in Treating Depression

Pairing Psilocybin With Stillness Could Permanently Rewire the Brain

GLP-1 Drugs Reduce Depression, Boost Stress-Calming Gut Bacteria

SSRIs Push Serotonin Neurons in Opposite Directions

Are Long-Term Antidepressant Benefits Overstated?

Arthritis Drug Rescues Hard-to-Treat Depression

Buprenorphin and Ketamine Combo Provide Anti-Suicidal Effect

Single Psilocybin Dose Sparks Rapid Depression Remission

Brain-Stimulating Contact Lenses Match Prozac in Depression Study

Psilocybin Rebuilds the Brain’s Physical Wiring

Single Cocaine Exposure Leaves a Long-Lasting Genetic Scar

Mild Sleep Restriction Drives Weight Gain and Inactivity

Astrocytes Actively Dictate Long-Term Memory Persistence

Brain Transforms Music into Movement by 12 Months of Age

Subscribe